与怀孕相关的血小板数量下降和妊娠期血小板缺血的遗传基础
Zijing Yang1,2, Liang Hu2, Jianxin Zhen3
1School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, China.
Blood
|December 8, 2023
概括
孕期血小板缺血 (GT) 是一种常见的怀孕并发症,原因不明. 这项研究确定了遗传因素,特别是PEAR1,影响妊娠期间血小板计数和GT风险.
科学领域:
- 遗传学 遗传学 是一个
- 产科 产科 产科 产科 产科
- 血液学 血液学 血液学
背景情况:
- 血小板数减少在怀孕期间很常见,影响5-12%的女性.
- 妊娠性血小板缺血 (GT) 涉及妊娠期间血小板数量的显著下降.
- 这些与怀孕相关的血小板变化背后的生物机制尚不清楚.
研究的目的:
- 为了研究整个怀孕期间血小板计数的遗传基础.
- 为了确定与妊娠性血小板缺血 (GT) 和严重GT的遗传关联.
- 探索特定基因,如PEAR1在与怀孕相关的血小板动态中的作用.
主要方法:
- 全基因组关联研究 (GWAS) 在100,186名中国孕妇的测序数据上进行.
- 血小板计数分析了五个怀孕时期的血小板计数:第一季度,第二季度,第三季度,分娩和产后.
- 评估了两个GT状态:GT (血小板数 < 150 × 10^9/L) 和严重GT (血小板数 < 100 × 10^9/L).
主要成果:
- 确定了138个全基因组显著位置,解释了血小板数变化的10.4%至12.1%.
- 在PEAR1和CBL的变种显示出在怀孕期间对血小板计数的基因影响改变.
- PEAR1变异与更快的血小板数下降有关,而PEAR1和TUBB1变异增加了对GT和严重GT的敏感性.
结论:
- 这项研究阐明了妊娠中血小板计数和GT的遗传基础.
- PEAR1在与怀孕相关的血小板减少和GT发生方面发挥着关键作用.
- 特定的遗传变异可能会使个人在怀孕期间更容易出现血小板减少和GT风险升高.
更多相关视频
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
847
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
578
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708
01:24Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
526
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
526
01:22Formation of the Platelet Plug
6.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.4K
01:18Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K